H.R. Lijnen

6.7k total citations
147 papers, 5.5k citations indexed

About

H.R. Lijnen is a scholar working on Cancer Research, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H.R. Lijnen has authored 147 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Cancer Research, 56 papers in Hematology and 40 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H.R. Lijnen's work include Protease and Inhibitor Mechanisms (106 papers), Blood Coagulation and Thrombosis Mechanisms (52 papers) and Blood properties and coagulation (37 papers). H.R. Lijnen is often cited by papers focused on Protease and Inhibitor Mechanisms (106 papers), Blood Coagulation and Thrombosis Mechanisms (52 papers) and Blood properties and coagulation (37 papers). H.R. Lijnen collaborates with scholars based in Belgium, France and Netherlands. H.R. Lijnen's co-authors include D Collen, B. Van Hoef, Désiré Collen, Valerie Christiaens, C Zamarrón, Marc Hoylaerts, B. Wiman, Erik Maquoi, Désiré Collen and Alain Colige and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

H.R. Lijnen

146 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.R. Lijnen Belgium 44 2.7k 1.8k 1.5k 1.2k 885 147 5.5k
H.R. Lijnen Belgium 52 4.3k 1.6× 3.2k 1.8× 2.5k 1.6× 1.8k 1.5× 1.7k 1.9× 192 9.2k
Egbert K. O. Kruithof Switzerland 43 2.1k 0.8× 1.9k 1.0× 1.4k 0.9× 713 0.6× 474 0.5× 102 4.9k
Lindsey A. Miles United States 41 3.2k 1.2× 1.9k 1.0× 2.4k 1.6× 792 0.7× 365 0.4× 99 6.2k
Toshihiko Terao Japan 43 1.2k 0.4× 876 0.5× 1.6k 1.1× 613 0.5× 689 0.8× 220 5.8k
Taro Hayakawa Japan 42 2.4k 0.9× 815 0.5× 1.8k 1.2× 288 0.2× 260 0.3× 140 5.7k
Graham C. Parry United States 36 1.4k 0.5× 1.2k 0.7× 1.7k 1.1× 274 0.2× 276 0.3× 75 5.0k
David H. Lovett United States 50 1.8k 0.7× 693 0.4× 2.5k 1.6× 563 0.5× 292 0.3× 126 6.6k
Ewa Paleolog United Kingdom 46 989 0.4× 829 0.5× 2.3k 1.5× 396 0.3× 440 0.5× 123 6.6k
C. Arnold Spek Netherlands 41 485 0.2× 1.5k 0.8× 1.7k 1.1× 651 0.6× 666 0.8× 165 5.1k
Barbara Ferris United States 28 687 0.3× 1.1k 0.6× 2.4k 1.5× 717 0.6× 246 0.3× 39 4.6k

Countries citing papers authored by H.R. Lijnen

Since Specialization
Citations

This map shows the geographic impact of H.R. Lijnen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.R. Lijnen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.R. Lijnen more than expected).

Fields of papers citing papers by H.R. Lijnen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.R. Lijnen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.R. Lijnen. The network helps show where H.R. Lijnen may publish in the future.

Co-authorship network of co-authors of H.R. Lijnen

This figure shows the co-authorship network connecting the top 25 collaborators of H.R. Lijnen. A scholar is included among the top collaborators of H.R. Lijnen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.R. Lijnen. H.R. Lijnen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lijnen, H.R.. (2009). Role of fibrinolysis in obesity and thrombosis. Thrombosis Research. 123. S46–S49. 44 indexed citations
2.
Nagai, N., B. Van Hoef, & H.R. Lijnen. (2007). Plasminogen activator inhibitor‐1 contributes to the deleterious effect of obesity on the outcome of thrombotic ischemic stroke in mice. Journal of Thrombosis and Haemostasis. 5(8). 1726–1731. 43 indexed citations
3.
Rossignol, Patrick, Aernout Luttun, José Luis Martín‐Ventura, et al.. (2005). Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques. Journal of Thrombosis and Haemostasis. 4(3). 664–670. 37 indexed citations
4.
Semeraro, Fabrizio, Gábor Vörös, D Collen, & H.R. Lijnen. (2005). Impairment of adipose tissue development by hypoxia is not mediated by plasminogen activator inhibitor-1. Thrombosis and Haemostasis. 95(1). 174–181. 2 indexed citations
5.
Lehoux, Stéphanie, Catherine A. Lemarié, Bruno Esposito, H.R. Lijnen, & Alain Tedgui. (2003). MMP-9 is a key modulator of pressure-induced remodeling in mouse carotid arteries. Circulation. 108. 165–166. 1 indexed citations
6.
Hamacher, Jürg, Rudolf Lucas, H.R. Lijnen, et al.. (2002). Tumor Necrosis Factor-α and Angiostatin Are Mediators of Endothelial Cytotoxicity in Bronchoalveolar Lavages of Patients with Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 166(5). 651–656. 81 indexed citations
7.
Lijnen, H.R., et al.. (2000). Inactivation of Plasminogen Activator Inhibitor-1 by Specific Proteolysis with Stromelysin-1 (MMP-3). Journal of Biological Chemistry. 275(48). 37645–37650. 50 indexed citations
8.
Morange, Pierre‐Emmanuel, Jacques Aubert, Franck Peiretti, et al.. (1999). Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue.. Diabetes. 48(4). 890–895. 95 indexed citations
9.
Lasters, Ignace, et al.. (1997). Enzymatic Properties of Phage‐Displayed Fragments of Human Plasminogen. European Journal of Biochemistry. 244(3). 946–952. 9 indexed citations
10.
Okada, K., et al.. (1996). Procoagulant Properties of Intravenous Staphylokinase Versus Tissue-Type Plasminogen Activator. Thrombosis and Haemostasis. 76(6). 857–859. 15 indexed citations
11.
Lijnen, H.R.. (1995). Mechanism of action and thrombolytic potential of staphylokinase.. PubMed. 57(4). 303–14. 2 indexed citations
12.
Ueshima, Shigeru, et al.. (1994). Expression and Characterization of Clustered Charge-to-Alanine Mutants of Low Mr Single-Chain Urokinase-Type Plasminogen Activator. Thrombosis and Haemostasis. 71(1). 134–140. 6 indexed citations
13.
Pujade-Lauraine, Éric, Lu H, J. Soria, et al.. (1993). The plasminogen‐activation system in ovarian tumors. International Journal of Cancer. 55(1). 27–31. 49 indexed citations
14.
Lijnen, H.R. & D Collen. (1992). Remaining Perspectives of Mutant and Chimeric Plasminogen Activators. Annals of the New York Academy of Sciences. 667(1). 357–364. 3 indexed citations
15.
Stassen, Jean Marie, I. Vanlinthout, H.R. Lijnen, & D Collen. (1990). A hamster pulmonary embolism model for the evaluation of the thrombolytic and pharmacokinetic properties of thrombolytic agents. Fibrinolysis and Proteolysis. 4. 15–21. 32 indexed citations
16.
Lijnen, H.R., L Nelles, B. Van Hoef, F De Cock, & D Collen. (1990). Biochemical and functional characterization of human tissue-type plasminogen activator variants obtained by deletion and/or duplication of structural/functional domains.. Journal of Biological Chemistry. 265(10). 5677–5683. 29 indexed citations
17.
Dewerchin, M, et al.. (1989). Biochemical properties of conjugates of urokinase‐type plasminogen activator with a monoclonal antibody specific for cross‐linked fibrin. European Journal of Biochemistry. 185(1). 141–149. 45 indexed citations
18.
Lijnen, H.R., B. Van Hoef, & Désiré Collen. (1987). Differential reactivity of Glu-Gly-Arg-CH2Cl, a synthetic urokinase inhibitor, with single-chain and two-chain forms of urokinase-type plasminogen activator. European Journal of Biochemistry. 162(2). 351–356. 18 indexed citations
19.
Lijnen, H.R. & D Collen. (1984). Molecular Mechanism of Fibrinolysis. Advances in experimental medicine and biology. 164. 217–228. 5 indexed citations
20.
Lijnen, H.R., B. Van Hoef, & Désiré Collen. (1981). On the Rolw of the Carbohydrate Side Chains of Human Plasminogen in Its Interaction with α2‐Antiplasmin and Fibrin. European Journal of Biochemistry. 120(1). 149–154. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H.R. Lijnen Breakdown of academic impact, for papers by Egbert K. O. Kruithof Breakdown of academic impact, for papers by Lindsey A. Miles Breakdown of academic impact, for papers by Toshihiko Terao Breakdown of academic impact, for papers by Taro Hayakawa Breakdown of academic impact, for papers by Graham C. Parry Breakdown of academic impact, for papers by David H. Lovett Breakdown of academic impact, for papers by Ewa Paleolog Breakdown of academic impact, for papers by C. Arnold Spek Breakdown of academic impact, for papers by Barbara Ferris
Rankless by CCL
2026